In addition to the above two pathways, m6A also affects the pathogenesis and progression of cancer through other classical pathways, such as the JAK-STAT1 pathway, ERK/JNK pathway, and NF-κB pathway, which may also provide directions for clinical therapy [55,61,131]. This evidence concerns the gene NFKB1 and cancer.